SG151103A1 - Remedy - Google Patents
RemedyInfo
- Publication number
- SG151103A1 SG151103A1 SG200700557-2A SG2007005572A SG151103A1 SG 151103 A1 SG151103 A1 SG 151103A1 SG 2007005572 A SG2007005572 A SG 2007005572A SG 151103 A1 SG151103 A1 SG 151103A1
- Authority
- SG
- Singapore
- Prior art keywords
- macrophages
- remedy
- exterminated
- pathogen
- dysfunction
- Prior art date
Links
- 210000002540 macrophage Anatomy 0.000 abstract 7
- 230000004064 dysfunction Effects 0.000 abstract 2
- 244000052769 pathogen Species 0.000 abstract 2
- 230000001717 pathogenic effect Effects 0.000 abstract 2
- 206010057249 Phagocytosis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000000242 pagocytic effect Effects 0.000 abstract 1
- 230000008782 phagocytosis Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/739—Lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- AIDS & HIV (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002247871 | 2002-08-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG151103A1 true SG151103A1 (en) | 2009-04-30 |
Family
ID=31972490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200700557-2A SG151103A1 (en) | 2002-08-27 | 2003-08-27 | Remedy |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US20060105048A1 (uk) |
| EP (2) | EP2343072A1 (uk) |
| JP (1) | JP3947999B2 (uk) |
| KR (3) | KR20110002877A (uk) |
| CN (4) | CN1678350A (uk) |
| AU (1) | AU2003261768B2 (uk) |
| BR (1) | BR0313881A (uk) |
| CA (2) | CA2496902C (uk) |
| DK (1) | DK1547615T3 (uk) |
| EA (1) | EA008107B1 (uk) |
| ES (1) | ES2575534T3 (uk) |
| HK (1) | HK1145463A1 (uk) |
| HU (1) | HUE030275T2 (uk) |
| MX (1) | MXPA05002209A (uk) |
| PL (3) | PL397023A1 (uk) |
| SG (1) | SG151103A1 (uk) |
| UA (1) | UA84276C2 (uk) |
| WO (1) | WO2004019982A1 (uk) |
| ZA (1) | ZA200502452B (uk) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007284362A (ja) * | 2006-04-13 | 2007-11-01 | Tokyo Univ Of Science | 薬物送達粒子及びその製造方法 |
| EA016540B1 (ru) * | 2008-12-30 | 2012-05-30 | Ооо "Научно-Производственный Комплекс "Наносистема" | Фармацевтическая композиция для лечения туберкулеза, способ ее получения и способ лечения туберкулеза |
| CN102647910A (zh) * | 2009-09-28 | 2012-08-22 | 杣源一郎 | 植物培育剂，植物病害抗性诱导剂，及植物病害控制方法 |
| JP5559173B2 (ja) | 2009-12-03 | 2014-07-23 | 株式会社アウレオ | マクロファージにおけるサイトカイン産生促進組成物 |
| US9962439B2 (en) * | 2013-10-03 | 2018-05-08 | Nitto Denko Corporation | Injectable vaccine composition |
| EP3387115B1 (en) * | 2015-12-08 | 2022-01-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for expanding a population of alveolar macrophages in a long term culture |
| EP3660078A4 (en) * | 2017-07-27 | 2021-04-21 | Samyang Biopharmaceuticals Corporation | METHOD FOR MANUFACTURING BIO-DEGRADABLE POLYMER MICROPARTICLES AND BIO-DEGRADABLE POLYMER MICROPARTICLES SO MANUFACTURED |
| KR200490892Y1 (ko) | 2019-02-26 | 2020-01-17 | 주식회사 남현 | 체압 연동형 의자 등받이 경사 조절기구 |
| KR102210240B1 (ko) | 2020-01-15 | 2021-02-01 | 주식회사 남현 | 탄성력 조절이 가능한 의자 등받이 경사 조절기구 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1739064A (en) * | 1922-12-29 | 1929-12-10 | Ind Waste Products Corp | Process for the manufacture of a sugar product |
| ATE153374T1 (de) * | 1990-08-20 | 1997-06-15 | Soma Genichiro | Lps-produzierende bakterien, lipopolysiccharide und lps enthaltende arzneimittel und tierärztliche medikamente |
| US5759583A (en) * | 1995-08-30 | 1998-06-02 | Syntex (U.S.A.) Inc. | Sustained release poly (lactic/glycolic) matrices |
| US6126919A (en) * | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
| EP1009390A4 (en) * | 1997-07-02 | 2004-05-06 | Euro Celtique Sa | LONG-EFFECT ANESTHESIA INJECTED IN JOINT AND BODY SPACES |
| JP4204085B2 (ja) * | 1997-10-08 | 2009-01-07 | オリジナル・イメージ株式会社 | マクロファージ活性化剤 |
| WO2000028969A2 (en) * | 1998-11-18 | 2000-05-25 | University Of Florida | Methods for preparing coated drug particles and pharmaceutical formulations thereof |
| JP4580479B2 (ja) * | 1998-12-21 | 2010-11-10 | 株式会社林原生物化学研究所 | 抗ｈｉｖ感染症剤 |
| US6406745B1 (en) * | 1999-06-07 | 2002-06-18 | Nanosphere, Inc. | Methods for coating particles and particles produced thereby |
| JP2002247871A (ja) | 2001-02-15 | 2002-08-30 | Matsushita Electric Ind Co Ltd | モータ制御装置及びモータ制御方法 |
-
2003
- 2003-08-27 EP EP11000496A patent/EP2343072A1/en not_active Withdrawn
- 2003-08-27 CN CNA038203278A patent/CN1678350A/zh active Pending
- 2003-08-27 WO PCT/JP2003/010871 patent/WO2004019982A1/ja active Application Filing
- 2003-08-27 EP EP03791347.2A patent/EP1547615B1/en not_active Expired - Lifetime
- 2003-08-27 CA CA2496902A patent/CA2496902C/en not_active Expired - Fee Related
- 2003-08-27 CN CNA200610114924XA patent/CN1935155A/zh active Pending
- 2003-08-27 CN CN2010101681488A patent/CN101862456B/zh not_active Expired - Fee Related
- 2003-08-27 CN CNA2006101149254A patent/CN1935156A/zh active Pending
- 2003-08-27 SG SG200700557-2A patent/SG151103A1/en unknown
- 2003-08-27 KR KR1020107026831A patent/KR20110002877A/ko not_active Application Discontinuation
- 2003-08-27 PL PL397023A patent/PL397023A1/pl unknown
- 2003-08-27 KR KR1020107026830A patent/KR20110002876A/ko not_active Application Discontinuation
- 2003-08-27 AU AU2003261768A patent/AU2003261768B2/en not_active Ceased
- 2003-08-27 JP JP2004532735A patent/JP3947999B2/ja not_active Expired - Fee Related
- 2003-08-27 DK DK03791347.2T patent/DK1547615T3/en active
- 2003-08-27 US US10/525,964 patent/US20060105048A1/en not_active Abandoned
- 2003-08-27 CA CA2706622A patent/CA2706622C/en not_active Expired - Fee Related
- 2003-08-27 UA UAA200502820A patent/UA84276C2/uk unknown
- 2003-08-27 PL PL397022A patent/PL397022A1/pl not_active Application Discontinuation
- 2003-08-27 BR BR0313881-0A patent/BR0313881A/pt not_active IP Right Cessation
- 2003-08-27 EA EA200500418A patent/EA008107B1/ru not_active IP Right Cessation
- 2003-08-27 ES ES03791347.2T patent/ES2575534T3/es not_active Expired - Lifetime
- 2003-08-27 HU HUE03791347A patent/HUE030275T2/en unknown
- 2003-08-27 MX MXPA05002209A patent/MXPA05002209A/es active IP Right Grant
- 2003-08-27 KR KR1020057003529A patent/KR101067971B1/ko not_active IP Right Cessation
- 2003-08-27 PL PL03375585A patent/PL375585A1/xx not_active IP Right Cessation
-
2005
- 2005-03-24 ZA ZA200502452A patent/ZA200502452B/en unknown
-
2010
- 2010-03-22 US US12/659,796 patent/US8425939B2/en not_active Expired - Fee Related
- 2010-12-23 HK HK10112021.6A patent/HK1145463A1/xx not_active IP Right Cessation
-
2013
- 2013-03-14 US US13/831,439 patent/US20130202663A1/en not_active Abandoned
-
2014
- 2014-03-21 US US14/221,606 patent/US20140206641A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY137757A (en) | Therapeutic treatment | |
| PA8588601A1 (es) | Administracion combinada de una indolinona junto a un agente quimioterapeutico para el tratamiento de enfermedades de proliferacion celular | |
| CY1105082T1 (el) | Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας | |
| CA119221S (en) | Blister package | |
| DE60327103D1 (de) | Darreichungsformen enthaltend einen protonpumphemmer, einen nsaid und einen puffer | |
| SG151103A1 (en) | Remedy | |
| USRE46162E1 (en) | Water closet | |
| CA107279S (en) | Foot/ankle brace | |
| TNSN05330A1 (en) | Tablet comprising fluvastatin and carmellose calcium | |
| PL1713438T3 (pl) | Mydło lecznicze | |
| ITMI20020630A0 (it) | Procedimento per l'esecuzione di una sacca in un manufatto tubolare particolarmente per l'esecuzione del tallone o della punta di calze con | |
| CA179403S (en) | Orthopedic brace | |
| HRP20040186B1 (en) | Use of lhrh-antagonists for the improvement of t-cell mediated immunity | |
| DE50309647D1 (de) | Ng fibrotischer erkrankungen | |
| IL181183A (en) | Use of an elastase inhibitor in the manufacture of a medicament for the treatment of leukemia | |
| AU309683S (en) | Massaging belt | |
| WO2004012732A3 (en) | Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy | |
| MX2007004040A (es) | Uso para alfa-simpatomimeticos con estructura de 2-imidazolina. | |
| CA104374S (en) | Electrical jack | |
| CA104435S (en) | High-chair | |
| HN2003000067A (es) | Lapiz de yema | |
| CA105222S (en) | Lavatory device | |
| CA96645S (en) | Foot for an article of furniture | |
| EP1689408A4 (en) | TREATMENT OF INFLAMMATORY DISORDERS OF EPITHELIUM USING LOW DOSE 2,3-BENZODIAZEPINES | |
| MD2066G2 (ro) | Remediu antihipertensiv |